Table 1.
Demographic characteristics of the children
| Pre-study medians (IQR) or n (%)a | Post-study medians (IQR) or n (%)a | |
|---|---|---|
| Age (years) | 3.7 (3.0–7.0) | – |
| Gender (female), n (%) | 28 (53) | – |
| Time on ART (months) | 20 (15–32) | – |
| Median viral load (log10) | 1.69 | 1.69 |
| Viral load <50 copies/ml | 43 (81) | 37 (70) |
| CD4 (%) | 30 (23–33) | 32 (27–33) |
| WHO stage at ART initiation | ||
| III, n (%) | 26 (49) | – |
| IV, n (%) | 11 (21) | – |
| ART regimen | ||
| d4T/3TC/LPV/r, n (%) | 20 (38) | – |
| d4T/3TC/EFV, n (%) | 19 (36) | – |
| AZT/3TC/LPV/r, n (%) | 6 (11) | – |
| AZT/3TC/EFV, n (%) | 3 (6) | – |
| Other | 5 (9) | – |
ART Antiretroviral treatment, d4T Stavudine, 3TC Lamivudine, LPV/r Lopinavir/ritonavir, EFV Efavirenz, AZT Zidovudine
aResults presented are median values with inter-quartile ranges, unless otherwise stated